nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0326	0.0405	CcSEcCtD
Raloxifene—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0319	0.0397	CcSEcCtD
Raloxifene—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0303	0.0376	CcSEcCtD
Raloxifene—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.03	0.0373	CcSEcCtD
Raloxifene—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0291	0.0362	CcSEcCtD
Raloxifene—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0279	0.0346	CcSEcCtD
Raloxifene—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0256	0.0318	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0255	0.0317	CcSEcCtD
Raloxifene—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0245	0.0304	CcSEcCtD
Raloxifene—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0223	0.0277	CcSEcCtD
Raloxifene—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0219	0.0273	CcSEcCtD
Raloxifene—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0212	0.0264	CcSEcCtD
Raloxifene—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0212	0.0264	CcSEcCtD
Raloxifene—CYP3A4—urine—nephrolithiasis	0.0211	0.108	CbGeAlD
Raloxifene—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0209	0.026	CcSEcCtD
Raloxifene—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0205	0.0255	CcSEcCtD
Raloxifene—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0196	0.0244	CcSEcCtD
Raloxifene—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0195	0.0242	CcSEcCtD
Raloxifene—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0194	0.0242	CcSEcCtD
Raloxifene—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0193	0.024	CcSEcCtD
Raloxifene—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0182	0.0226	CcSEcCtD
Raloxifene—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0209	CcSEcCtD
Raloxifene—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0204	CcSEcCtD
Raloxifene—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0153	0.019	CcSEcCtD
Raloxifene—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0153	0.019	CcSEcCtD
Raloxifene—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.015	0.0186	CcSEcCtD
Raloxifene—Cough—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0185	CcSEcCtD
Raloxifene—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0145	0.018	CcSEcCtD
Raloxifene—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0145	0.018	CcSEcCtD
Raloxifene—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0145	0.018	CcSEcCtD
Raloxifene—AOX1—nephron tubule—nephrolithiasis	0.0143	0.0733	CbGeAlD
Raloxifene—Shock—Hydrochlorothiazide—nephrolithiasis	0.0137	0.017	CcSEcCtD
Raloxifene—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0169	CcSEcCtD
Raloxifene—ESR2—renal system—nephrolithiasis	0.0135	0.0692	CbGeAlD
Raloxifene—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0167	CcSEcCtD
Raloxifene—ESR2—kidney—nephrolithiasis	0.0131	0.0669	CbGeAlD
Raloxifene—AOX1—renal system—nephrolithiasis	0.013	0.0666	CbGeAlD
Raloxifene—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0158	CcSEcCtD
Raloxifene—AOX1—kidney—nephrolithiasis	0.0126	0.0644	CbGeAlD
Raloxifene—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0156	CcSEcCtD
Raloxifene—AOX1—cortex of kidney—nephrolithiasis	0.0123	0.0627	CbGeAlD
Raloxifene—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0152	CcSEcCtD
Raloxifene—Pain—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0148	CcSEcCtD
Raloxifene—SIGMAR1—nephron tubule—nephrolithiasis	0.0115	0.059	CbGeAlD
Raloxifene—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0141	CcSEcCtD
Raloxifene—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.011	0.0137	CcSEcCtD
Raloxifene—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.011	0.0137	CcSEcCtD
Raloxifene—SIGMAR1—cortex of kidney—nephrolithiasis	0.00987	0.0505	CbGeAlD
Raloxifene—HTR2B—cortex of kidney—nephrolithiasis	0.00985	0.0504	CbGeAlD
Raloxifene—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00952	0.0118	CcSEcCtD
Raloxifene—ESR1—renal system—nephrolithiasis	0.00927	0.0474	CbGeAlD
Raloxifene—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0092	0.0114	CcSEcCtD
Raloxifene—ESR1—kidney—nephrolithiasis	0.00896	0.0458	CbGeAlD
Raloxifene—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00885	0.011	CcSEcCtD
Raloxifene—Rash—Hydrochlorothiazide—nephrolithiasis	0.00877	0.0109	CcSEcCtD
Raloxifene—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00877	0.0109	CcSEcCtD
Raloxifene—Headache—Hydrochlorothiazide—nephrolithiasis	0.00872	0.0108	CcSEcCtD
Raloxifene—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00827	0.0103	CcSEcCtD
Raloxifene—CYP2C8—renal system—nephrolithiasis	0.00764	0.039	CbGeAlD
Raloxifene—CYP2B6—nephron tubule—nephrolithiasis	0.00754	0.0385	CbGeAlD
Raloxifene—CYP2C8—kidney—nephrolithiasis	0.00738	0.0377	CbGeAlD
Raloxifene—CYP2B6—renal system—nephrolithiasis	0.00685	0.035	CbGeAlD
Raloxifene—CYP2B6—kidney—nephrolithiasis	0.00662	0.0338	CbGeAlD
Raloxifene—CYP3A4—renal system—nephrolithiasis	0.00517	0.0264	CbGeAlD
Raloxifene—CYP3A4—kidney—nephrolithiasis	0.005	0.0256	CbGeAlD
